{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:20:45Z","timestamp":1777479645798,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/ijo.2013.111","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T07:36:26Z","timestamp":1371540986000},"page":"432-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Association of anemia with the risk of cardiovascular adverse events in overweight\/obese patients"],"prefix":"10.1038","volume":"38","author":[{"given":"S A","family":"Winther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Finer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-6131","authenticated-orcid":false,"given":"C","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,18]]},"reference":[{"key":"BFijo2013111_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3324\/haematol.13449","volume":"94","author":"E Riva","year":"2009","unstructured":"Riva E, Tettamanti M, Mosconi P, Apolone G, Gandini F, Nobili A et al. Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica 2009; 94: 22\u201328.","journal-title":"Haematologica"},{"key":"BFijo2013111_CR2","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/archinte.165.19.2214","volume":"165","author":"NA Zakai","year":"2005","unstructured":"Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005; 165: 2214\u20132220.","journal-title":"Arch Intern Med"},{"key":"BFijo2013111_CR3","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1182\/blood-2005-10-4308","volume":"107","author":"BF Culleton","year":"2006","unstructured":"Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR . Impact of anemia on hospitalization and mortality in older adults. Blood 2006; 107: 3841\u20133846.","journal-title":"Blood"},{"key":"BFijo2013111_CR4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/gerona\/63.8.873","volume":"63","author":"X Dong","year":"2008","unstructured":"Dong X, Mendes de LC, Artz A, Tang Y, Shah R, Evans D . A population-based study of hemoglobin, race, and mortality in elderly persons. J Gerontol A Biol Sci Med Sci 2008; 63: 873\u2013878.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"BFijo2013111_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/gerona\/61.5.474","volume":"61","author":"BW Penninx","year":"2006","unstructured":"Penninx BW, Pahor M, Woodman RC, Guralnik JM . Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci 2006; 61: 474\u2013479.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"BFijo2013111_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0735-1097(02)01938-1","volume":"40","author":"MJ Sarnak","year":"2002","unstructured":"Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002; 40: 27\u201333.","journal-title":"J Am Coll Cardiol"},{"key":"BFijo2013111_CR7","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.amjcard.2010.01.001","volume":"105","author":"K Tsujita","year":"2010","unstructured":"Tsujita K, Nikolsky E, Lansky AJ, Dangas G, Fahy M, Brodie BR et al. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol 2010; 105: 1385\u20131394.","journal-title":"Am J Cardiol"},{"key":"BFijo2013111_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jacc.2008.04.044","volume":"52","author":"IS Anand","year":"2008","unstructured":"Anand IS . Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008; 52: 501\u2013511.","journal-title":"J Am Coll Cardiol"},{"key":"BFijo2013111_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2369-11-27","volume":"11","author":"FP Del","year":"2010","unstructured":"Del FP, Luthi JC, Carrera E, Michel P, Burnier M, Burnand B . Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study. BMC Nephrol 2010; 11: 27.","journal-title":"BMC Nephrol"},{"key":"BFijo2013111_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.2012.39","volume":"307","author":"KM Flegal","year":"2012","unstructured":"Flegal KM, Carroll MD, Kit BK, Ogden CL . Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010. JAMA 2012; 307: 491\u2013497.","journal-title":"JAMA"},{"key":"BFijo2013111_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1024\/0300-9831\/a000033","volume":"80","author":"AC Cepeda-Lopez","year":"2010","unstructured":"Cepeda-Lopez AC, Aeberli I, Zimmermann MB . Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms. Int J Vitam Nutr Res 2010; 80: 263\u2013270.","journal-title":"Int J Vitam Nutr Res"},{"key":"BFijo2013111_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1753-4887.2008.00145.x","volume":"67","author":"JP McClung","year":"2009","unstructured":"McClung JP, Karl JP . Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev 2009; 67: 100\u2013104.","journal-title":"Nutr Rev"},{"key":"BFijo2013111_CR13","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ijo.2008.43","volume":"32","author":"MB Zimmermann","year":"2008","unstructured":"Zimmermann MB, Zeder C, Muthayya S, Winichagoon P, Chaouki N, Aeberli I et al. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes 2008; 32: 1098\u20131104.","journal-title":"Int J Obes"},{"key":"BFijo2013111_CR14","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/oby.2006.198","volume":"14","author":"A Lecube","year":"2006","unstructured":"Lecube A, Carrera A, Losada E, Hernandez C, Simo R, Mesa J . Iron deficiency in obese postmenopausal women. Obesity 2006; 14: 1724\u20131730.","journal-title":"Obesity"},{"key":"BFijo2013111_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1542\/peds.114.1.104","volume":"114","author":"KG Nead","year":"2004","unstructured":"Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M . Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004; 114: 104\u2013108.","journal-title":"Pediatrics"},{"key":"BFijo2013111_CR16","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","volume":"53","author":"CJ Lavie","year":"2009","unstructured":"Lavie CJ, Milani RV, Ventura HO . Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925\u20131932.","journal-title":"J Am Coll Cardiol"},{"key":"BFijo2013111_CR17","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa1003114","volume":"363","author":"WP James","year":"2010","unstructured":"James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010; 363: 905\u2013917.","journal-title":"N Engl J Med"},{"key":"BFijo2013111_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.ajkd.2005.05.011","volume":"46","author":"JC Verhave","year":"2005","unstructured":"Verhave JC, Fesler P, Ribstein J, du CG, Mimran A . Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005; 46: 233\u2013241.","journal-title":"Am J Kidney Dis"},{"key":"BFijo2013111_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.amjcard.2008.10.023","volume":"103","author":"N Meneveau","year":"2009","unstructured":"Meneveau N, Schiele F, Seronde MF, Descotes-Genon V, Oettinger J, Chopard R et al. Anemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol 2009; 103: 442\u2013447.","journal-title":"Am J Cardiol"},{"key":"BFijo2013111_CR20","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","volume":"111","author":"MS Sabatine","year":"2005","unstructured":"Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042\u20132049.","journal-title":"Circulation"},{"key":"BFijo2013111_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","volume":"107","author":"JA Ezekowitz","year":"2003","unstructured":"Ezekowitz JA, McAlister FA, Armstrong PW . Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223\u2013225.","journal-title":"Circulation"},{"key":"BFijo2013111_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/1874192401004010173","volume":"4","author":"M Charlot","year":"2010","unstructured":"Charlot M, Torp-Pedersen C, Valeur N, Seibaek M, Weeke P, Kober L . Anaemia and long term mortality in heart failure patients: a retrospective study. Open Cardiovasc Med J 2010; 4: 173\u2013177.","journal-title":"Open Cardiovasc Med J"},{"key":"BFijo2013111_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2377-10-22","volume":"10","author":"D Tanne","year":"2010","unstructured":"Tanne D, Molshatzki N, Merzeliak O, Tsabari R, Toashi M, Schwammenthal Y . Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study. BMC Neurol 2010; 10: 22.","journal-title":"BMC Neurol"},{"key":"BFijo2013111_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/00005373-199609000-00006","volume":"41","author":"PS Levy","year":"1996","unstructured":"Levy PS, Quigley RL, Gould SA . Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. J Trauma 1996; 41: 416\u2013423.","journal-title":"J Trauma"},{"key":"BFijo2013111_CR25","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/01.CIR.74.5.1085","volume":"74","author":"AS Most","year":"1986","unstructured":"Most AS, Ruocco NA Jr., Gewirtz H . Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation 1986; 74: 1085\u20131092.","journal-title":"Circulation"},{"key":"BFijo2013111_CR26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ahj.2006.06.014","volume":"152","author":"S Muzzarelli","year":"2006","unstructured":"Muzzarelli S, Pfisterer M . Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J 2006; 152: 991\u2013996.","journal-title":"Am Heart J"},{"key":"BFijo2013111_CR27","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1038\/oby.2008.353","volume":"16","author":"KJ Ausk","year":"2008","unstructured":"Ausk KJ, Ioannou GN . Is obesity associated with anemia of chronic disease? A population-based study. Obesity (Silver Spring) 2008; 16: 2356\u20132361.","journal-title":"Obesity (Silver Spring)"},{"key":"BFijo2013111_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jada.2007.10.034","volume":"108","author":"CM Menzie","year":"2008","unstructured":"Menzie CM, Yanoff LB, Denkinger BI, McHugh T, Sebring NG, Calis KA et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 2008; 108: 145\u2013148.","journal-title":"J Am Diet Assoc"},{"key":"BFijo2013111_CR29","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3945\/ajcn.110.005439","volume":"93","author":"AC Cepeda-Lopez","year":"2011","unstructured":"Cepeda-Lopez AC, Osendarp SJ, Melse-Boonstra A, Aeberli I, Gonzalez-Salazar F, Feskens E et al. Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake. Am J Clin Nutr 2011; 93: 975\u2013983.","journal-title":"Am J Clin Nutr"},{"key":"BFijo2013111_CR30","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1053\/j.gastro.2006.07.007","volume":"131","author":"S Bekri","year":"2006","unstructured":"Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006; 131: 788\u2013796.","journal-title":"Gastroenterology"},{"issue":"10","key":"BFijo2013111_CR31","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1038\/oby.2009.490","volume":"18","author":"Lisa M. Tussing-Humphreys","year":"2010","unstructured":"Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Holterman AX, Galvani C et al. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity 2010; 18 2010-6.","journal-title":"Obesity"},{"key":"BFijo2013111_CR32","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1111\/j.1755-5922.2010.00240.x","volume":"29","author":"E Lipsic","year":"2011","unstructured":"Lipsic E, van der Meer P, van Veldhuisen DJ . Erythropoiesis-stimulating agents and heart failure. Cardiovasc Ther 2011; 29: e52\u2013e59.","journal-title":"Cardiovasc Ther"},{"key":"BFijo2013111_CR33","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ahj.2011.02.013","volume":"161","author":"D Kotecha","year":"2011","unstructured":"Kotecha D, Ngo K, Walters JA, Manzano L, Palazzuoli A, Flather MD . Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials. Am Heart J 2011; 161: 822\u2013831.","journal-title":"Am Heart J"},{"key":"BFijo2013111_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/eurjhf\/hfp098","volume":"11","author":"JJ McMurray","year":"2009","unstructured":"McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA et al. Design of the reduction of events with Darbepoetin alfa in heart failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial. Eur J Heart Fail 2009; 11: 795\u2013801.","journal-title":"Eur J Heart Fail"},{"key":"BFijo2013111_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11892-010-0123-5","volume":"10","author":"AK Singh","year":"2010","unstructured":"Singh AK . Diabetes, anemia and CKD: Why TREAT? Curr Diab Rep 2010; 10: 291\u2013296.","journal-title":"Curr Diab Rep"},{"key":"BFijo2013111_CR36","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1161\/CIRCULATIONAHA.111.030411","volume":"124","author":"H Skali","year":"2011","unstructured":"Skali H, Parving HH, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P et al. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation 2011; 124: 2903\u20132908.","journal-title":"Circulation"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijo2013111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2013111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2013111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T18:05:50Z","timestamp":1647367550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2013111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,18]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["BFijo2013111"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2013.111","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,18]]},"assertion":[{"value":"19 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The co-authors Professor Finer, Professor Sharma and Professor Torp-Pedersen declare that they received consultancy fees from Abbott Laboratories as members of the SCOUT (Sibutramine Cardiovascular Outcome Trial) Executive Steering Committee until 2011. Nick Finer reports that he has received honoraria from Roche, Sanofi Avenitis and Novo Nordisk for lectures and board memberships in various drug trials. He is also a stockholder in Counterweight plc. The remaining authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}